Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance

Cell Metabolism

Volumn 15, Issue 5, 2012, Pages 574-584

  Jornayvaz, François R ^a   Shulman, Gerald I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; PROTEIN KINASE C EPSILON; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE;

ENZYME ACTIVATION; FATTY LIVER; GENE EXPRESSION; GENETIC PREDISPOSITION; GLUCONEOGENESIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID OXIDATION; LIPODYSTROPHY; LIVER; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIGLYCERIDES; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIVER; MICE; PROTEIN KINASE C-EPSILON;

ANIMALIA;

EID: 84860497397     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.03.005     Document Type: Review

References (83)

1. M. Agostini, E. Schoenmakers, C. Mitchell, I. Szatmari, D. Savage, A. Smith, O. Rajanayagam, R. Semple, J. Luan, and L. Bath Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance Cell Metab. 4 2006 303 311 (Pubitemid 44430916)
2. P. Angulo Nonalcoholic fatty liver disease N. Engl. J. Med. 346 2002 1221 1231
3. J.E. Ayala, V.T. Samuel, G.J. Morton, S. Obici, C.M. Croniger, G.I. Shulman, D.H. Wasserman, O.P. McGuinness NIH Mouse Metabolic Phenotyping Center Consortium Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice Dis Model Mech 3 2010 525 534
4. D.E. Befroy, K.F. Petersen, S. Dufour, G.F. Mason, R.A. de Graaf, D.L. Rothman, and G.I. Shulman Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients Diabetes 56 2007 1376 1381 (Pubitemid 46715630)
5. A.L. Birkenfeld, H.Y. Lee, F. Guebre-Egziabher, T.C. Alves, M.J. Jurczak, F.R. Jornayvaz, D. Zhang, J.J. Hsiao, A. Martin-Montalvo, and A. Fischer-Rosinsky Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice Cell Metab. 14 2011 184 195
6. A.L. Birkenfeld, H.Y. Lee, S. Majumdar, M.J. Jurczak, J.P. Camporez, F.R. Jornayvaz, D.W. Frederick, B. Guigni, M. Kahn, and D. Zhang Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolism J. Biol. Chem. 286 2011 36163 36170
7. G. Boden, P. She, M. Mozzoli, P. Cheung, K. Gumireddy, P. Reddy, X. Xiang, Z. Luo, and N. Ruderman Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver Diabetes 54 2005 3458 3465 (Pubitemid 43334336)
8. G. Boden, X. Duan, C. Homko, E.J. Molina, W. Song, O. Perez, P. Cheung, and S. Merali Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals Diabetes 57 2008 2438 2444
9. J.M. Brown, J.L. Betters, C. Lord, Y. Ma, X. Han, K. Yang, H.M. Alger, J. Melchior, J. Sawyer, and R. Shah CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance J. Lipid Res. 51 2010 3306 3315
10. C.S. Choi, J.J. Fillmore, J.K. Kim, Z.X. Liu, S. Kim, E.F. Collier, A. Kulkarni, A. Distefano, Y.J. Hwang, and M. Kahn Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance J. Clin. Invest. 117 2007 1995 2003 (Pubitemid 47036334)
11. C.S. Choi, D.B. Savage, L. Abu-Elheiga, Z.X. Liu, S. Kim, A. Kulkarni, A. Distefano, Y.J. Hwang, R.M. Reznick, and R. Codella Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity Proc. Natl. Acad. Sci. USA 104 2007 16480 16485 (Pubitemid 350211044)
12. C.S. Choi, D.E. Befroy, R. Codella, S. Kim, R.M. Reznick, Y.J. Hwang, Z.X. Liu, H.Y. Lee, A. Distefano, and V.T. Samuel Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism Proc. Natl. Acad. Sci. USA 105 2008 19926 19931
13. H. Cortez-Pinto, J. Chatham, V.P. Chacko, C. Arnold, A. Rashid, and A.M. Diehl Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study JAMA 282 1999 1659 1664 (Pubitemid 29513973)
14. S.T. Crooke Progress in antisense technology Annu. Rev. Med. 55 2004 61 95 (Pubitemid 38316716)
15. D.R. Dries, L.L. Gallegos, and A.C. Newton A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production J. Biol. Chem. 282 2007 826 830 (Pubitemid 47076514)
16. D.M. Erion, I.D. Ignatova, S. Yonemitsu, Y. Nagai, P. Chatterjee, D. Weismann, J.J. Hsiao, D. Zhang, T. Iwasaki, and R. Stark Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein Cell Metab. 10 2009 499 506
17. E. Fabbrini, F. Magkos, B.S. Mohammed, T. Pietka, N.A. Abumrad, B.W. Patterson, A. Okunade, and S. Klein Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity Proc. Natl. Acad. Sci. USA 106 2009 15430 15435
18. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
19. G. Frangioudakis, J.G. Burchfield, S. Narasimhan, G.J. Cooney, M. Leitges, T.J. Biden, and C. Schmitz-Peiffer Diverse roles for protein kinase C delta and protein kinase C epsilon in the generation of high-fat-diet-induced glucose intolerance in mice: regulation of lipogenesis by protein kinase C delta Diabetologia 52 2009 2616 2620
20. S. Gandotra, C. Le Dour, W. Bottomley, P. Cervera, P. Giral, Y. Reznik, G. Charpentier, M. Auclair, M. Delépine, and I. Barroso Perilipin deficiency and autosomal dominant partial lipodystrophy N. Engl. J. Med. 364 2011 740 748
21. A. Gastaldelli, Y. Miyazaki, M. Pettiti, E. Buzzigoli, S. Mahankali, E. Ferrannini, and R.A. DeFronzo Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis J. Clin. Endocrinol. Metab. 89 2004 3914 3921 (Pubitemid 39071494)
22. M.E. Griffin, M.J. Marcucci, G.W. Cline, K. Bell, N. Barucci, D. Lee, L.J. Goodyear, E.W. Kraegen, M.F. White, and G.I. Shulman Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade Diabetes 48 1999 1270 1274 (Pubitemid 29241025)
23. G.S. Hotamisligil Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes Diabetes 54 Suppl 2 2005 S73 S78
24. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867 (Pubitemid 46024993)
25. G.S. Hotamisligil Inflammation and endoplasmic reticulum stress in obesity and diabetes Int. J. Obes. (Lond.) 32 Suppl. 7 2008 S52 S54
26. F.R. Jornayvaz, M.J. Jurczak, H.Y. Lee, A.L. Birkenfeld, D.W. Frederick, D. Zhang, X.M. Zhang, V.T. Samuel, and G.I. Shulman A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain Am. J. Physiol. Endocrinol. Metab. 299 2010 E808 E815
27. F.R. Jornayvaz, V.T. Samuel, and G.I. Shulman The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome Annu. Rev. Nutr. 30 2010 273 290
28. F.R. Jornayvaz, A.L. Birkenfeld, M.J. Jurczak, S. Kanda, B.A. Guigni, D.C. Jiang, D. Zhang, H.Y. Lee, V.T. Samuel, and G.I. Shulman Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2 Proc. Natl. Acad. Sci. USA 108 2011 5748 5752
29. F.R. Jornayvaz, H.Y. Lee, M.J. Jurczak, T.C. Alves, F. Guebre-Egziabher, B.A. Guigni, D. Zhang, V.T. Samuel, J.E. Silva, and G.I. Shulman Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance Endocrinology 153 2012 583 591
30. M.J. Jurczak, A.H. Lee, F.R. Jornayvaz, H.Y. Lee, A.L. Birkenfeld, B.A. Guigni, M. Kahn, V.T. Samuel, L.H. Glimcher, and G.I. Shulman Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice J. Biol. Chem. 287 2012 2558 2567
31. K. Kantartzis, A. Peter, F. Machicao, J. Machann, S. Wagner, I. Königsrainer, A. Königsrainer, F. Schick, A. Fritsche, H.U. Häring, and N. Stefan Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene Diabetes 58 2009 2616 2623
32. J.K. Kim, O. Gavrilova, Y. Chen, M.L. Reitman, and G.I. Shulman Mechanism of insulin resistance in A-ZIP/F-1 fatless mice J. Biol. Chem. 275 2000 8456 8460 (Pubitemid 30180190)
33. J.K. Kim, M.D. Michael, S.F. Previs, O.D. Peroni, F. Mauvais-Jarvis, S. Neschen, B.B. Kahn, C.R. Kahn, and G.I. Shulman Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle J. Clin. Invest. 105 2000 1791 1797 (Pubitemid 30421760)
34. J.K. Kim, J.J. Fillmore, Y. Chen, C. Yu, I.K. Moore, M. Pypaert, E.P. Lutz, Y. Kako, W. Velez-Carrasco, and I.J. Goldberg Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance Proc. Natl. Acad. Sci. USA 98 2001 7522 7527 (Pubitemid 32567981)
35. J.K. Kim, A. Zisman, J.J. Fillmore, O.D. Peroni, K. Kotani, P. Perret, H. Zong, J. Dong, C.R. Kahn, B.B. Kahn, and G.I. Shulman Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4 J. Clin. Invest. 108 2001 153 160 (Pubitemid 32634932)
36. J.K. Kim, J.J. Fillmore, O. Gavrilova, L. Chao, T. Higashimori, H. Choi, H.J. Kim, C. Yu, Y. Chen, and X. Qu Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice Diabetes 52 2003 1311 1318 (Pubitemid 36666182)
37. K. Kotani, O.D. Peroni, Y. Minokoshi, O. Boss, and B.B. Kahn GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization J. Clin. Invest. 114 2004 1666 1675 (Pubitemid 40385558)
38. N. Kumashiro, D.M. Erion, D. Zhang, M. Kahn, S.A. Beddow, X. Chu, C.D. Still, G.S. Gerhard, X. Han, and J. Dziura Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease Proc. Natl. Acad. Sci. USA 108 2011 16381 16385
39. M.A. Lazar How obesity causes diabetes: not a tall tale Science 307 2005 373 375 (Pubitemid 40139971)
40. H.Y. Lee, C.S. Choi, A.L. Birkenfeld, T.C. Alves, F.R. Jornayvaz, M.J. Jurczak, D. Zhang, D.K. Woo, G.S. Shadel, and W. Ladiges Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance Cell Metab. 12 2010 668 674
41. H.Y. Lee, A.L. Birkenfeld, F.R. Jornayvaz, M.J. Jurczak, S. Kanda, V. Popov, D.W. Frederick, D. Zhang, B. Guigni, and K.G. Bharadwaj Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance Hepatology 54 2011 1650 1660
42. E.L. Lim, K.G. Hollingsworth, B.S. Aribisala, M.J. Chen, J.C. Mathers, and R. Taylor Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol Diabetologia 54 2011 2506 2514
43. D. Liska, S. Dufour, T.L. Zern, S. Taksali, A.M. Calí, J. Dziura, G.I. Shulman, B.M. Pierpont, and S. Caprio Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents PLoS ONE 2 2007 e569
44. A.B. Mayerson, R.S. Hundal, S. Dufour, V. Lebon, D. Befroy, G.W. Cline, S. Enocksson, S.E. Inzucchi, G.I. Shulman, and K.F. Petersen The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes Diabetes 51 2002 797 802 (Pubitemid 34760191)
45. Y. Miyazaki, L. Glass, C. Triplitt, E. Wajcberg, L.J. Mandarino, and R.A. DeFronzo Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus Am. J. Physiol. Endocrinol. Metab. 283 2002 E1135 E1143
46. Y. Miyazaki, A. Mahankali, M. Matsuda, S. Mahankali, J. Hardies, K. Cusi, L.J. Mandarino, and R.A. DeFronzo Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients J. Clin. Endocrinol. Metab. 87 2002 2784 2791 (Pubitemid 34655345)
47. M. Monetti, M.C. Levin, M.J. Watt, M.P. Sajan, S. Marmor, B.K. Hubbard, R.D. Stevens, J.R. Bain, C.B. Newgard, and R.V. Farese Sr. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab. 6 2007 69 78 (Pubitemid 46995777)
48. G. Montero-Moran, J.M. Caviglia, D. McMahon, A. Rothenberg, V. Subramanian, Z. Xu, S. Lara-Gonzalez, J. Storch, G.M. Carman, and D.L. Brasaemle CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase J. Lipid Res. 51 2010 709 719
49. K. Morino, K.F. Petersen, S. Dufour, D. Befroy, J. Frattini, N. Shatzkes, S. Neschen, M.F. White, S. Bilz, and S. Sono Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents J. Clin. Invest. 115 2005 3587 3593 (Pubitemid 43121847)
50. K. Morino, K.F. Petersen, S. Sono, C.S. Choi, V.T. Samuel, A. Lin, A. Gallo, H. Zhao, A. Kashiwagi, and I.J. Goldberg Regulation of mitochondrial biogenesis by lipoprotein lipase in muscle of insulin resistant offspring of parents with type 2 diabetes Diabetes 61 2012 877 887
51. Y. Nagai, S. Yonemitsu, D.M. Erion, T. Iwasaki, R. Stark, D. Weismann, J. Dong, D. Zhang, M.J. Jurczak, and M.G. Löffler The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance Cell Metab. 9 2009 252 264
52. S. Neschen, K. Morino, L.E. Hammond, D. Zhang, Z.X. Liu, A.J. Romanelli, G.W. Cline, R.L. Pongratz, X.M. Zhang, and C.S. Choi Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn- 3-phosphate acyltransferase 1 knockout mice Cell Metab. 2 2005 55 65 (Pubitemid 43239825)
53. A.C. Newton Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm Biochem. J. 370 2003 361 371 (Pubitemid 36315124)
54. E.A. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar, P. Snell, A.J. Wagner, A.M. DePaoli, M.L. Reitman, and S.I. Taylor Leptin-replacement therapy for lipodystrophy N. Engl. J. Med. 346 2002 570 578 (Pubitemid 34438818)
55. U. Ozcan, Q. Cao, E. Yilmaz, A.H. Lee, N.N. Iwakoshi, E. Ozdelen, G. Tuncman, C. Görgün, L.H. Glimcher, and G.S. Hotamisligil Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457 461 (Pubitemid 39372439)
56. U. Ozcan, E. Yilmaz, L. Ozcan, M. Furuhashi, E. Vaillancourt, R.O. Smith, C.Z. Görgün, and G.S. Hotamisligil Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes Science 313 2006 1137 1140 (Pubitemid 44300242)
57. G. Perseghin, T.B. Price, K.F. Petersen, M. Roden, G.W. Cline, K. Gerow, D.L. Rothman, and G.I. Shulman Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects N. Engl. J. Med. 335 1996 1357 1362 (Pubitemid 26360454)
58. K.F. Petersen, E.A. Oral, S. Dufour, D. Befroy, C. Ariyan, C. Yu, G.W. Cline, A.M. DePaoli, S.I. Taylor, P. Gorden, and G.I. Shulman Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy J. Clin. Invest. 109 2002 1345 1350 (Pubitemid 34546899)
59. K.F. Petersen, D. Befroy, S. Dufour, J. Dziura, C. Ariyan, D.L. Rothman, L. DiPietro, G.W. Cline, and G.I. Shulman Mitochondrial dysfunction in the elderly: possible role in insulin resistance Science 300 2003 1140 1142 (Pubitemid 36583097)
60. K.F. Petersen, S. Dufour, D. Befroy, R. Garcia, and G.I. Shulman Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N. Engl. J. Med. 350 2004 664 671 (Pubitemid 38364625)
61. K.F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R.E. Hendler, and G.I. Shulman Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 2005 603 608 (Pubitemid 40322060)
62. K.F. Petersen, S. Dufour, J. Feng, D. Befroy, J. Dziura, C. Dalla Man, C. Cobelli, and G.I. Shulman Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men Proc. Natl. Acad. Sci. USA 103 2006 18273 18277 (Pubitemid 44871648)
63. K.F. Petersen, S. Dufour, D.B. Savage, S. Bilz, G. Solomon, S. Yonemitsu, G.W. Cline, D. Befroy, L. Zemany, and B.B. Kahn The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome Proc. Natl. Acad. Sci. USA 104 2007 12587 12594 (Pubitemid 47255198)
64. K.F. Petersen, S. Dufour, A. Hariri, C. Nelson-Williams, J.N. Foo, X.M. Zhang, J. Dziura, R.P. Lifton, and G.I. Shulman Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N. Engl. J. Med. 362 2010 1082 1089
65. T.S. Pillay, J. Whittaker, and K. Siddle Phorbol ester-induced downregulation of protein kinase C potentiates insulin receptor tyrosine autophosphorylation: evidence for a major constitutive role in insulin receptor regulation Biochem. Soc. Trans. 18 1990 494 495 (Pubitemid 20181127)
66. R. Rabol, K.F. Petersen, S. Dufour, C. Flannery, and G.I. Shulman Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals Proc. Natl. Acad. Sci. USA 108 2011 13705 13709
67. R.R. Rando, and N. Young The stereospecific activation of protein kinase C Biochem. Biophys. Res. Commun. 122 1984 818 823
68. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, L.A. Pennacchio, E. Boerwinkle, J.C. Cohen, and H.H. Hobbs Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat. Genet. 40 2008 1461 1465
69. V.T. Samuel, Z.X. Liu, X. Qu, B.D. Elder, S. Bilz, D. Befroy, A.J. Romanelli, and G.I. Shulman Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease J. Biol. Chem. 279 2004 32345 32353 (Pubitemid 39014687)
70. V.T. Samuel, Z.X. Liu, A. Wang, S.A. Beddow, J.G. Geisler, M. Kahn, X.M. Zhang, B.P. Monia, S. Bhanot, and G.I. Shulman Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease J. Clin. Invest. 117 2007 739 745 (Pubitemid 46348532)
71. D.B. Savage, C.S. Choi, V.T. Samuel, Z.X. Liu, D. Zhang, A. Wang, X.M. Zhang, G.W. Cline, X.X. Yu, and J.G. Geisler Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2 J. Clin. Invest. 116 2006 817 824 (Pubitemid 43326891)
72. J.E. Schaffer, and H.F. Lodish Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein Cell 79 1994 427 436 (Pubitemid 24346058)
73. A.I. Schmid, J. Szendroedi, M. Chmelik, M. Krssák, E. Moser, and M. Roden Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes Diabetes Care 34 2011 448 453
74. I. Shimomura, R.E. Hammer, S. Ikemoto, M.S. Brown, and J.L. Goldstein Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 1999 73 76
75. S.E. Shoelson, J. Lee, and A.B. Goldfine Inflammation and insulin resistance J. Clin. Invest. 116 2006 1793 1801 (Pubitemid 44033299)
76. G.I. Shulman Cellular mechanisms of insulin resistance J. Clin. Invest. 106 2000 171 176 (Pubitemid 30483118)
77. N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, and H.U. Häring Identification and characterization of metabolically benign obesity in humans Arch. Intern. Med. 168 2008 1609 1616
78. N.E. Sunny, E.J. Parks, J.D. Browning, and S.C. Burgess Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease Cell Metab. 14 2011 804 810
79. S. Takayama, M.F. White, and C.R. Kahn Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity J. Biol. Chem. 263 1988 3440 3447 (Pubitemid 18072805)
80. G. Taubes Insulin resistance. Prosperity's plague Science 325 2009 256 260
81. M. Tiikkainen, A.M. Häkkinen, E. Korsheninnikova, T. Nyman, S. Mäkimattila, and H. Yki-Järvinen Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes Diabetes 53 2004 2169 2176 (Pubitemid 38970772)
82. C. Yu, Y. Chen, G.W. Cline, D. Zhang, H. Zong, Y. Wang, R. Bergeron, J.K. Kim, S.W. Cushman, and G.J. Cooney Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle J. Biol. Chem. 277 2002 50230 50236 (Pubitemid 36042170)
83. D. Zhang, Z.X. Liu, C.S. Choi, L. Tian, R. Kibbey, J. Dong, G.W. Cline, P.A. Wood, and G.I. Shulman Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance Proc. Natl. Acad. Sci. USA 104 2007 17075 17080 (Pubitemid 350210994)